Revenue | ₹30.87Cr |
Net Profits | ₹3.45Cr |
Net Profit Margins | 11.18% |
Indo US Bio-Tech Ltd’s revenue jumped 39.12% since last year same period to ₹30.87Cr in the Q2 2025-2026. On a quarterly growth basis, Indo US Bio-Tech Ltd has generated 0.32% jump in its revenue since last 3-months.
Indo US Bio-Tech Ltd’s net profit fell -20.87% since last year same period to ₹3.45Cr in the Q2 2025-2026. On a quarterly growth basis, Indo US Bio-Tech Ltd has generated -26.6% fall in its net profits since last 3-months.
Indo US Bio-Tech Ltd’s net profit margin fell -43.12% since last year same period to 11.18% in the Q2 2025-2026. On a quarterly growth basis, Indo US Bio-Tech Ltd has generated -26.83% fall in its net profit margins since last 3-months.
The revenue for Indo US Bio-Tech Ltd in the Q2 results 2025 was ₹30.87Cr.
The net profit for Indo US Bio-Tech Ltd in the Q2 results 2025 was ₹3.45Cr.
The net profit margin for Indo US Bio-Tech Ltd in the Q2 results 2025 was 11.18%.
The revenue for Indo US Bio-Tech Ltd in the Q2 results 2024 was ₹22.19Cr.
The net profit for Indo US Bio-Tech Ltd in the Q2 results 2024 was ₹4.36Cr.
The net profit margin for Indo US Bio-Tech Ltd in the Q2 results 2024 was 19.65%.